Role of nitric oxide in modulating mucosal integrity and in contributing to gastrointestinal inflammation;Role du monoxyde d'azote dans le maintien de l'integrite muqueuse et dans la pathologie inflammatoire gastro-intestinale

Gastroenterologie Clinique et Biologique

Volumn 20, Issue 12, 1996, Pages 1085-1098

  Lamarque, Dominique ^a   Kiss, József ^a   Whittle, Brendan ^b   Delchier, Jean Charles ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

colon; inflammation; intestine; mucosa; nitric oxide; stomach

Indexed keywords

NITRIC OXIDE;

COLON; DIGESTIVE SYSTEM INFLAMMATION; HUMAN; INTESTINE MUCOSA; PATHOPHYSIOLOGY; REVIEW; STOMACH; ENTERITIS; IMMUNOLOGY; PHYSIOLOGY; STOMACH MUCOSA; VASCULARIZATION;

GASTRIC MUCOSA; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; NITRIC OXIDE;

EID: 0030339506     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (213)

1. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate; nitic oxide is an intermediate. Biochemistry 1988; 27: 8706-11.
2. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
3. Garthwaite J, Charles SL, Chess-Williams R. Endotheliumderived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain. Nature 1988;336:385-8.
4. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
5. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxic 1984;24:175-97.
6. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9.
7. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-26.
8. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nilrosothiols as actives intermediates. J Pharmacol Exp Ther 1981;218:739-49.
9. Feelisch M, Noack EA. Correlation betwenn nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987;139:19-30.
10. Amezcua JL, Dusting GJ, Palmer RMJ, Moncada S. Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilatator. Br J Pharmacol 1988;95:830-4.
11. Kelm M, Feelisch M, Spahr R, Piper HM, Noack E, Schrader J. Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem Biophys Res Commun 1988;154:236-44.
12. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988;153:1251-6.
13. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation Br J Pharmacol 1989;96:418-24.
14. Amezcua JL, Palmer RMJ, De Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation in the rabbit. Br J Pharmacol 1989;97:1119-24.
15. Aisaka K, Gross SS, Griffith OW, Levi R. NG-methylarginine, an inhibitor of endothelium-derived nitic oxide synthesis is a potent pressor agent in the guinea-pig: does nitric oxide regulate blood pressure in vivo ? Biochem Biophys Res Commun 1989;160:881-6.
16. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-8.
17. Gardner SM, Compton AM, Bennett T, Palmer RMJ, Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 1990;15:486-92.
18. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriole tone in man. Lancet 1989;2:997-1000.
19. Moncada S,Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
20. Galmiche A, Rozé C, Scarpignato C, Galmiche JP. Monoxyde d'azote (NO), médiateur des influences non-adrénergiques non-cholinergiques du système nerveux entérique, et motricité œso-gastrique. Gastroenterol Clin Biol 1995;19:36-49.
21. Brown JF, Tepperman BL, Hanson PJ, Whittle BJR, Moncada S. Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochem Biophys Res Commun 1992; 184:680-5.
22. Palmer RMJ, Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 1989;158:348-52.
23. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally ressembles cytochrome P-450 reductase. Nature 1991;351:714-8.
24. Kwon NS, Nathan CF, Gilker C, Griffith OW, Matthews DE, Stuehr DJ. L-citrulline production from L-arginine by macrophage nitric oxide synthase: the ureido oxygen derives from dioxygen. J Biol Chem 1990;265:13442-5.
25. Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL, Wiseman J. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 1991;266:6259-93.
26. Leone AM, Palmer RMJ, Knowles RG, Francis PL, Ashton DS, Moncada S. Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline. J Biol Chem 1991;266:23790-5.
27. Mayer B, John M, Heinzel B, Werner ER, Wachter H, Schultz G et al. Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett 1991;288:187-91.
28. Pollock JS, Klinghofer V, Förstermann U, Murad F. Endothelial nitric oxide synthase is myristylated. FEBS Lett 1992;309:402-9.
29. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992;89:6348-52.
30. Nishida K, Harrison DG, Navas JP, Fisher M, Dockery SP, Uematsu M et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992;90:2092-6.
31. Xu W, Charles IG, Moncada S, Gorman P, Sheer D, Liu L et al. Mapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectively. Genomics 1994;21:419-22.
32. Weiner CP, Lizasoain I, Baylis S, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994;91:5212-6.
33. Lamontagne D, Pohl U, Busse R, Mechanical deformation of vessel wall and shear stress determine the basal EDRF release in the intact coronary vascular bed. Cir Res 1992;70:123-30.
34. Hutcheson IR. Griffith TM. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. Am J Physiol 1991;70:123-30.
35. Pohl U, Busse R. Hypoxia stimulates the release of endothelium-derived relaxant factor (EDRF), Am J Physiol 1989;256:H1595-H1600.
36. Marsden PA, Heng HHQ, Sherer SW, Stewart RJ, Hall AV, Shi XM, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993;268:478-88.
37. Liao JK, Zulueta JJ, Yu FS, Peng HB, Cote CG, Hassoun PM. Regulation of bovine constitutive nitric oxide synthase by oxygen, J Clin Invest 1995;:96:2661-6.
38. Knowles RG, Merret M, Slater N, Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem J 1990;270:833-6.
39. Schmidt HHW, Gagne GD, Nakane M, Pollock JS, Miller MF, Murad F. Mapping of neutral nitric oxide synthase in the rat suggests frequent calocalization with NADPH diaphorase but not with soluble guanyl cyclase and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem 1992;10:1439-56.
40. Nichols K, Staines W, Krantis A. Nitric oxide synthase distribution in the rat intestine: a histochemical analysis. Gastroenterology 1993;105:1651-61.
41. Pique JM, Whittle BJR, Esplugues JV. The vasodilatator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol 1989;174:293-6.
42. Pique JN, Pizcueta MP, Bosch J, Fernandez M, Whittle BJR, Moncada S. Role of nitric oxide in the hyperdynamic splanchnic circulation of portal hypertensive rats. In: Moncada S, Marietta MA, Hibbs JB, Higgs EA, eds. Biology of nitric oxide, vol 1. London: Portland Press, 1992;60-4.
43. Iwata F, Joh T, Kawai T, Itoh M. Role of EDRF in splanchnic blood flow of normal and chronic portal hyperensive rats. Am J Physiol 1992;263:G149-54.
44. Pique JM, Esplugues JV, Whittle BJR, Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion. Gastroenterology 1992;102:168-74.
45. Holzer P, Livingston EH, Guth PH. Neural, metabolic, physical, and endothelial factors in the regulation of the gastric circulation. In:Johnson LR,ed. Physiology of the gastrointestinal tract. 3rd ed. New York: Raven, 1994:1311-29.
46. Whittle BJR, Lopez Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990;99:607-11.
47. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilatators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 1991;17:(Suppl.3):S25-33.
48. Kitawaga H, Tokeda F, Kohei H. Effect of endothelium-derived relaxing factor on the gastric lesion induced by HCl in rats. J Pharmacol Exp Ther 1990;253:1133-7.
49. Mac Naughton K, Cirino G, Wallace JL. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989;45:1869-76.
50. Brain SD, Williams TJ, Tippins JR, Moris HR, Macintyre I. Calcitonin gene-related peptide is a potent vasodilatator. Nature 1985;313:54-6.
51. Holzer P. Capsaicin: Cellular targets, mechanism of action, and selectivity for thin sensory neurones. Pharmacol Rev 1991;43:143-201.
52. Peskar BM, Respondek M, Muller KM, Peskar BA. A role of nitric oxide in capsaicin-induced gastroprotection. Eur J Pharmacol 1991;198:113-4.
53. Whittle BJR, Lopez-Belmonte J, Moncada S. Nitric oxide mediates rat mucosal vasodilatation induced by intragastric capsaicin. Eur J Pharmacol 1992;218:339-41.
54. Brown JF, Hanson PJ, Whittle BJR. Nitric oxide donors increase mucus gel thickness in rat stomach. Eur J Pharmacol 1992;223:103-4.
55. Brown JF, Keates AC, Hanson PJ, Whittle BJR. Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am J Physiol 1993;265:G418-22.
56. Price KJ, Hanson PJ, Whittle BJR. Stimulation by carbachol of mucus thickness in rat stomach involves nitric oxide. Eur J Pharmacol 1994;263:199-202.
57. - secretion by the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester in rats. J Gastroenterol Hepatol 1994;9:S50-4.
58. Nylander O, Hallgren A, Holm L. Duodenal mucosal alkaline secretion, permeability, and blood flow. Am J Physiol 1993;265:G1029-38.
59. Warner TD, De Nucci G, Vane JR. Comparison of the survival of endothelium-derived relaxing factor and nitric oxide within the isolated perfused mesenteric arterial bed of the rat. Br J Pharmacol 1989;97:777-82.
60. Moore PK, Al-Swayeh OA, Chong NWS, Evans RA, Gibson A. L-NG-Nitroarginine (L-NOARG) a novel L-arginine-reversible inhibitor of endothelium dependent vasodilatation in vitro. Br J Pharmacol 1990;99:408-12.
61. Harlan JM, Harker LA, Reidy MA, Gadjusek CM, Schwartz SM, Striker GE. Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest 1983;48:269-74.
62. Meyrick BO, Ryan US, Brigham KL. Direct effect of E. coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimai explants. Am J Pathol 1986;122:140-51.
63. Wallace JL, Steel G, Whittle BJR, Lagente V, Vargaftig B. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology 1987;93:765-73.
64. Boughton-Smith NK, Hutcheson I, Whittle BJ. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. Prostaglandins 1989;38:319-33,
65. Cybulsky NME, Chan MK, Movat HZ. Acute inflammation and microthrombosis induced by endotoxin, IL-1, and TNF and their implication in gram negative infection. Lab Invest 1988;58:365-78.
66. Hutcheson IR, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990;101:815-20.
67. Kubes P. Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 1993;264:G143-9.
68. Boughton-Smith NK, Hutcheson I, Deakin AM, Whittle BJR, Moncada S. Protective effect of S-nitro-S-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 1990;191:485-8.
69. Boughton-Smith NK, Berry S, Evans SM, Whittle BJR, Moncada S. Intestinal damage and the induction of nitric oxide synthase by endotoxin in the rat. Gastroenterology 1992;102:A598.
70. Szabo S, Trier JS, Brown A, Scnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 1984;88:228-36.
71. Robins PG. Ultra-structural observations on the pathogenesis of aspirin-induced gastric erosions. Br J Exp Pathol 1980;61:497-504.
72. Guth PH, Paulsen G, Nagata H. Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: effect of prostaglandin cytoprotection. Gastroenterology 1984;87:1083-90.
73. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
74. Smith SM, Holm-Rutili L, Perry MA, Grisham MN, Arfors KE, Granter DN et al. Role of neutrophils in hemorrhagic shock-induced gastric mucosal injury in the rat. Gastroenterology 1987;93:466-71.
75. Kubes P, Suzuki M, Granger DN. Platelet-ativating factor induced microvascular dysfunction: role of adherent leukocytes. Am J Physiol 1990;258:G158-63.
76. Kvietys PR, Twohig B, Danzell J, Specian RD. Ethanol-induccd injury to the rat gastric mucosa: role of neutrophils and xanthine oxidase-derived radicals. Gastroenterology 1990;98:909-20.
77. Wallace JL, Arfors KE, McKnight GW. A monoclonal antibody against the CD 18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 1991;100:878-83.
78. Pabst MJ, Johnston RB. Increased production of Superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolyssacharide. J Exp Med 1980;151:101-14.
79. Sachs T, Moldow CF, Cruddock PR, Bowers TK, Jacobs HS. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest 1978;61:1161-7.
80. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endotehlium-derived vascular relaxing factor. Nature 1986;320:454-6.
81. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-27.
82. McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S. Synthesis of nitric oxide form L-arginine by neutrophils. Release and interaction with Superoxide anion. Biochem J 1989;261:293-6.
83. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyle-endothelial cell adhesion. J Leukoc Biol 1994;55:662-75.
84. Wallace JL, Whittle BJR. Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins 1986;31:989-98.
85. Korthuis RJ, Anderson DC, Granger DN. Role of neutrophilendothelial cell adhesion in inflammatory disorders. J Crit Care 1994;9:1-26.
86. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P. Nitric oxide prevents leukocyte adherence: role of Superoxide. Am J Physiol 1993;265:H862-7.
87. Kurose I, Kubes P, Wolf RE, Anderson DC, Paulson JC, Miyasaka M et al. Inhibition of nitric oxide production: mechanisms of vascular albumin leakage. Cir Res 1993;73:164-71.
88. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987;92:181-7.
89. Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987;148:1482-9.
90. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in a portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983;244:052-7.
91. Pizcueta P, Piqué JM, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992;105:184-90.
92. Pizcueta P, Piqué JM, Fernandez M, Bosch J, Whittle BJR, Moncada S. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992;103:1909-15.
93. Lee FY, Albilos A, Colombato L, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 1992;16:1043-8.
94. Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993p;104:1750-4.
95. Fernandez M, Garcia-Pagan JC, Casadevall M, Bernadich C, Piera C, Whittle BJR et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portalhypertensive rats. Gastroentetrology 1995;108:1487-95.
96. Weigert AL, Martin PY, Niederberger M, Higa EMS, McMurtry IF, Gines P, et al. Endothelium-dependent vascular hyporesponsiveness whithout detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 1995;22:1856-62.
97. Ding JW, Andersson R, Soltesz V, Willen R, Bengmark S. The role of bile and bile acids in bacterial translocation in obstructive jaundnice in rats. Eur Surg Res 1993;25:11-9.
98. Ennis M, Clements B, Campbell GR, Halliday MI, Barclay RG, Rowlands BJ. The effect of obstructive jaundice on systemic concentrations of bile acids, histamine and antibodies to the core region of endotoxin glycolipid. Agents Actions 1993;38 (Suppl C):C283-5.
99. Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 1994;20:1343-50.
100. Ferraz JGP, Wallace JL. Prostaglandins modulate the responsiveness of the gastric microcirculation to sodium nitroprusside in cirrhotic rats. Hepatology 1996;23:123-9.
101. Hegesh E, Shiloah J. Blood nitrates and infantile methemoglobinemia. Clin Chim Acta 1982;125:107-15.
102. Wagner DA, Young VR, Tannenbaum SR. Mammalian nitrate biosynthesis: incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA 1983;80:4518-21.
103. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis; mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopoiysaccharide. Proc Natl Acad Sci USA 1985;82:7738-42.
104. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cylotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:81-94.
105. Amber IJ, Hibbs JB, Taintor RR, Vavrin Z. The L-arginine dependent effector mechanism is induced in murine adenocarci-noma cells by culture supernatant from cytotoxic activated macrophages. J Leukocyte Biol 1988;43:187-92.
106. Tayeh MA, Marletta MA. Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate. Tetrahydrobiopterin is required as a co-factor. J Biol Chem 1989;264:19654-8.
107. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992;256:225-8.
108. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 1992;267:6370-4.
109. Lowenstein CJ, Glatt GS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 1992;89:6711-5.
110. Chartain NA, Geller DA, Koty PP, Sitrin NF, Nussler EP, Hoffman EP et al. Molecular cloning, structure, and chromosomal localization of the inducible nitric oxide synthase gene. J Biol Chem 1994;269:6765-72.
111. Gross SS, Jaffe EA, Levi R, Kilbourn RG. Cytokine activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun 1991;178:823-9.
112. Curran RD, Billiar TR, Stuher DJ, Hofman K, Simmons RL. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989;170:1769-74.
113. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1993;191:89-94.
114. Wood ER, Berger H, Sherman PA, Lapetina EG. Hepatocytes and macrophages express an identical cytokine inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1993;191:767-74.
115. Charles LC, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, Hall VS. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 1993;90:11419-23.
116. Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, Simmons RL. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 1989;169:1467-72.
117. Lin JY, Seguin R, Keller K, Chadee K. Transforming growth factor-β1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica, Immunology 1995;85:400-7.
118. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocyles. Proc Natl Acad Sci USA 1993;90:522-6.
119. Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995;3:1184-95.
120. Stevens-Truss R, Marletta MA. Interaction of calmodulin with the inducible murine macrophage nitric oxide synthase. Biochemistry 1995;34:15638-45.
121. Anagli J, Hofmann F, Quadroni M, Vorherr T, Carafoli E. The calmodulin-binding domain of the inducible (macrophage) nitric oxide synthase. Eur J Biochem 1995;233:701-8.
122. Cho HJ, Xie Q, Calaycay J, Mumford RA, Swiderek KM, Lee TD et al. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 1992;176:599.
123. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-5.
124. Sherman PA, Laubach VE, Reep BR, Wood ER. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 1993;32:11600-5.
125. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN- containing flavoprotein. Proc Natl Acad Sci USA 1991;88:7773-7.
126. ++ independent nitric oxide synthase. FEBS Lett 1991;292:145-9.
127. Palmer RMJ, Andrews T, Foxwell NA, Moncada S. Glucocorticoids do not affect the induction of a novel calcium-dependent nitric oxide synthase in rabbit chondrocytes. Biochem Biophys Res Commun 1992;188:209-15.
128. ++ selectively supress IL-1-induced NO production by reducing iNOS mRNA stability. J Cell Biol 1995;129:1651-1657.
129. Tzeng E, Billiar T, Robbins PD, Loftus M, Stuehr DJ. Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer. Proc Natl Acad Sci USA 1995;92:11771-5.
130. Vodovotz Y, Kwon NS, Pospischil M, Manning J, Paik J, Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-γ and bacterial LPS. J Immunol 1994;152:4110-8.
131. Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharride. J Exp Med 1993;177:1779-1784.
132. Martin E, Nathan C, Xie QW. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994;180:977-84.
133. Xie Qw, Kashiwabara Y, Nathan C. Role of transcription factor NF-KB/ Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
134. Cox GW, Mathieson BJ, Gandino L, Blasi E, Radzioch D, Varesio L. Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst 1989;81:1492-6.
135. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 1993;178:605-13.
136. Mauel J, Ransijn A, Corradin SB, Buchmüller-Rouiller. Effects of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-γ and TNF-α. J Leukocyte Biol 1995;58:217-24.
137. Jun CD, Choi BM, Kim SU, Lee SY, Kim HM, Chung HT. Down-regulation of transforming factor-β gene expression by antisense oligodeoxynucleotides increases recombinant interferon-γ-induced nitric oxide synthesis in murine peritoneal macrophages. Immunology 1995;85:114-9.
138. Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C. Traces of bacterial lipopolysaccharide supress IFN-gamma-induced nitric oxide synthase gene expression in primary mouse macrophages. J Immunol 1993;151:301-9.
139. Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary macrophages. J Leukocyte Biol 1994;55:227-33.
140. Cetkovic-Cvrlje M, Sandier S, Eizirik DL. Nicotinamide and dexamethasone inhibit interleukin-1 induced nitric oxide production by RINm5F cells without decreasing messenger ribonucleic acid expression for nitric oxide synthase. Endocrinology 1993;133:1739-43.
141. Kunz D, Walker G, Eberhardt W, Pfeilschifter J. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1b-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc Natl Acad Sci USA 1996;93:255-9.
142. Bastian N, Hibbs JB. Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr Opin Immunol 1994;6:131-9.
143. Sheffler LA, Wink DA, Melillo G, Cox GW. Exogenous nitric oxide regulates IFN-γ plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages. J Immunol 1995;155:886-94.
144. Stuehr DJ, Gross SS, Sakuma I, Levi R, Nathan CF. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med 1989;169:1011-20.
145. Drapier JC, Hibbs JB. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 1988;140:2829-38.
146. Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumor cell ribonucleotide reductase reductase by macrophagc-derived nitric oxide. J Exp Med 1991;174:761-7.
147. Lopez-Belmonte J, Whittle BJR, Moncada S. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 1993;108:73-8.
148. Palmer RMJ, Bridge L, Foxwell NA, Moncada S. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 1992;105:11-2.
149. Laszlo F, Whittle BJR, Moncada S. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol 1994;111:1309-15.
150. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
151. Lamarque D, Whittle BJR. Role of oxygen-derived metabolites in the rat gastric mucosal injury induced by nitric oxide donors. Eur J Pharmacol 1995;277:187-94.
152. Rachmilewitz D, Stamler JS, Karmelli F, Mullins ME, Singel DJ, Loscalzo J et al. Peroxynitrite-induced rat colitis. A new model of colonic inflammation. Gastroenterology 1993;105:1681-8.
153. Munoz-Fernandez MA, Fernandez MA, Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism, Immunol Lett 1992;33:35-40.
154. James SL, Glaven J. Macrophage cytotoxicity against shistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J Immunol 1989;143:4208-12.
155. Vincendeau P, Daulouede S, Veyret B, Darde ML, Bouteille B, Lemesre JL. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp Parasitol 1992;75:353-60.
156. Granger DI, Hibbs JB, Perfect JR, Durack DT. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest 1988;81:1129-36.
157. Adams LB, Hibbs JB, Taintor RR, Krahenbuhl JL. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 1990;144:2725-9.
158. Malawista SE, Montgomery RR, Van Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. J Clin Invest 1992;90:631-6.
159. Kremsner PG, Nussler AK, Neifer S, Chaves MF, Bienzle U, Senaldi G et al. Malaria antigen and cytokines induced production of reactive nitrogen intermediates by macrophages has no impact on the development of experimental malaria. Immunology 1993;78:286-90.
160. Roach TIA, Barton CH, Chartterjee D, Liew FY, Black well JM. Opposing effects of interferon-γ on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarahinomannan-stimulated macrophages. Immunology 1995;85:106-13.
161. Hoffman RA, Langrehr JM, Billiar TR, Curran RD, Simmons RL. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 1990;145:2220-6.
162. Albina JE, Henry WL, Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J Surg Res 1991;50:403-9.
163. Mills CD. Molecular basis of « suppressor » macrophages: arginine metabolism via the nitric oxide synthetase pathway. J Immunol 1991;146:2719-23.
164. Langrehr JM, Hoffman RA, Billiar TR, Lee KKW, Schraut WH, Simmons RL. Nitric oxide synthesis in the in vivo allogtaft response: a possible regulatory mechanism. Surgery 1991;110:335-42.
165. Albina JE, Mills CD, Henry WL, Caldwell MD. Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway. J Immunol 1989;143:3641-6.
166. Keller R, Keist R, Joller P, Mülsch A. Coordinate up- and down-modulation of inducible nitric oxide synthase, nitric oxide production, and tumoricidal activity in rat bone-marrow-derived mononuclear phagocytes by lipopolysaccharide and gramnegative bacteria. Biochem Biophys Res Commun 1995;211:183-9.
167. Albina JE, Cui S, Mateo RB, Reicner JS. Nitric oxide-medicated apoptosis in murine peritoneal macrophages. J Immunol 1993;150:5080-5.
168. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995;375:408-11.
169. MacMicking JD, Nathan C, Horn G, Chartrain N, Fletcher DS, Trumbauer M et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995;81:641-50.
170. Taylor-Robinson AW, Phillips RS, Severn A, Moncada S, Liew FY. The role of Th1 and Th2 cells in a rodent malaria infection. Science 1993;260:1931-4.
171. Taylor-Robinson AW, Liew FY, Severn A, Xu D, Macsorley SJ, Garside Pet al. Regulation of the immune response by nitric oxide differentially produced by T helper 1 and T helper type 2 cells. Eur J Immunol 1994;24;980-4,
172. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995;92:4392-6.
173. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-4.
174. Tepperman BL, Brown JF, Whittle JR. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993;265:0214-8.
175. Tepperman BL, Brown JF, Korolkiewicz R, Whittle JR, Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: Effect of endotoxin challenge. J Pharmacol Exp Ther 1994;271:1477-82.
176. Brown JF, Tepperman BL, Hanson PJ, Whittle BJR. Lipopolysac-charide induces Ca(2+)-independent nitric oxide synthase activity in rat gastric mucosal cells. Eur J Pharmacol. 1994;292:111-4.
177. Reynolds PD, Middleton SJ, Hunter JO, Facer P, Bishop A, Evans T et al. High expression of iNOS in colonic mucosa in ulcerative colitis (abstract). Gastroenterology 1995;108:A903.
178. Boughton-Smith NK, Evans SM, Whittle BJR. Characterisation of nitric oxide synthase activity in the rat colonic mucosa and muscle after endotoxin and in a model of colitis. Agents Actions 1994;41 (Special Conference Issue):C223-5.
179. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S. Kakkis JL, Clark DA. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1993;264:11-6.
180. Grisham MB, Specian RD, ZimmermanTE. Effects of nitric oxide synthase inhibition on the pathobiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther 1994;271:1114-21.
181. Ribbons KA, Zhang XJ, Thompson JH, Greenberg SS, Moore WM, Kornmeier CM et al. Potential role of nitric oxide in a model of chronic colitis in rhesus macaque. Gastroenterology 1995;108:705-11.
182. Roediger WE, Lawson MJ, Nance SH, Radcliffe BC. Detectable colonic nitrite levels in inflammatory bowel disease-mucosal or bacterial malfunction ? Digestion 1986;35:199-204.
183. Boughton -Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJR, Moncada. Nitric oxide synthase activity in ulcerative colitis. Lancet 1993;342:338-40.
184. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993;341:465-66.
185. Lundberg JON, Hellström PM, Lundberg JM, Alving K. Greatly increased lunimal nitric oxide in ulcerative colitis. Lancet 1994;344:1673-4.
186. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995;36:718-23.
187. Rachmilewitz D, Karmeli F, Eliakim R, Stalnikowicz R, Ackerman Z, Amir G et al. Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients. Gut 1994;35:1394-7.
188. Nielsen H, Birkholz, Andersen LP, Moran AP. Neutrophil activation by Helicobacter pylori lipopolysaccharides. J Inf Dis 1994;170:135-9.
189. Lamarque D, Tankovic J, Dutreuil C, Delchier JC. Induction of nitric oxide synthase by an extract of Helicobacter pylori (Hp) in rat duodenum (abstract). Gastroenterology 1995;108:A143.
190. Bogle RG, Baydoun AR, Pearson JD, Moncada S, Mann GE. L-Arginine transport is increased in macrophages generating nitric oxide. Biochem J 1992;284:15-8.
191. Closs EI, Lyons CR, Kelly C, Cunningham JM. Characterization of the third member of the MCAT family of cationic amino acid transporters. Identification of a domain that determines the transport properties of the MCAT proteins. J Biol Chem 1993;268:20796-800.
192. Hortelano S, Genaro AM, Bosca L. Phorbol esters induce nitric oxide synthase and increase arginine influx in cultured peritoneal macrophages. FEBS Lett 1993;320:135-9.
193. Sato H, Fujiwara M, Bannai S. Effect of lipopolysaccharide on transport and metabolism of arginine in mouse peritoneal macrophages. J Leukoc Biol 1992;52:161-4.
194. Sax HC, Hasselgren PO, Talamini MA, Edwards LL, Fisher JF. Amino acid uptake in isolated, perfused liver: Effect of trauma and sepsis. J Surg Res 1988;45:50-5.
195. Beaudet AL, O'Brien WE, Bock HGO, Freytag SO, Su TS. The human arginosuccinate synthetase locus and citrullinemia. Adv Hum Genet 1986;15:161-96.
196. Nussler A, Billiar TR, Liu ZZ, Morris SM. Coinduction of nitricoxide synthase and arginosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production. J Biol Chem 1994;269:1257-61.
197. Liew FY, Li Y, Severn A, Millott S, Schmidt J, Salter M, Moncada S. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol 1991;21:2489-94.
198. Bogdan C, Vodovotz Y, Nathan CF. Macrophage deactivation by 1L-10. J Exp Med 1991;174:1549-55.
199. Ding AH, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factor-β1, -β2 and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol 1990;145:940-944.
200. Hibbs JB, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase activity and imino nitrogen oxidation to nitrite. Science 1987;235:473-6.
201. Hibbs JB, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987;138:550-65.
202. Dwyer MA, Bredt DS, Snyder SH. Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Commun 1991;176:1136-41.
203. Furfine ES, Harmon MF, Paith JE, Garvey EP. Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry 1993;32:8512-7.
204. Buxton IL, Cheek DJ, Exkman D, Westfall DP, Sanders KM, Keef DK. NG-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 1993;72:387-95.
205. Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R et al. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 1991;5:98-103.
206. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Scei USA 1990;87:682-5.
207. Förstermann U, Pollock JS, Schmidt HHW, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991;88:1788-92.
208. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL et al. Aminoguanidine, a novel inhibitor of nitric oxide formation prevents diabetic vascular dysfunction. Diabetes 1992;41:552-6.
209. Laszlo F, Evans SM, Whittle BJR. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol 1995; 272:169-75.
210. Southan GJ, Szabo C, Thiemermann C. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 1995;114:510-6.
211. Szabo C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:12472-6.
212. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-7.
213. Aeberhard EE, Henderson SA, Arabolos NS, Griscavage JM, Castro FE, Barrett CT et al. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1995;208:1053-9.